Intrathecal gadolinium-enhanced MR-cisternography: depiction of the subarachnoidal space and evaluation of gadobenat-dimeglumin-(Gd-BOPTA, "Multihance") toxicity in an animal model and a clinical case.

[1]  R. Wenzel,et al.  Gadolinium-myelocisternography for cerebrospinal fluid rhinorrhoea , 2000, Neuroradiology.

[2]  A. Danieli,et al.  GADOBENATE DIMEGLUMINE AND CEREBRAL GLUCOSE METABOLISM , 2000 .

[3]  A. Danieli,et al.  Gadobenate dimeglumine and cerebral glucose metabolism: Continuous monitoring of striatal lactate levels in freely moving rats , 2000, Acta radiologica.

[4]  B. Hamm,et al.  Clinical utility and safety of MultiHance in magnetic resonance imaging of liver cancer: results of multicenter studies in Europe and the USA. , 1999, Journal of computer assisted tomography.

[5]  A. Danieli,et al.  Neurotolerability of gadobenate dimeglumine. Evaluation of brain dopamine concentration in freely moving rats by microdialysis. , 1999, Investigative radiology.

[6]  L. Miragoli,et al.  Neurotolerability of gadobenate dimeglumine in a rat model of focal brain ischemia: EEG evaluation. , 1999, Investigative radiology.

[7]  R. F. Williams,et al.  Evaluation of gadopentetate dimeglumine magnetic resonance cisternography in an animal model: preliminary report. , 1999, Investigative radiology.

[8]  J. Holton,et al.  Neurotoxic potential of gadodiamide after injection into the lateral cerebral ventricle of rats. , 1998, AJNR. American journal of neuroradiology.

[9]  B. Jenkins,et al.  Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. , 1997, Investigative radiology.

[10]  M. Pélaprat,et al.  Brain penetration and neurological effects of gadobenate dimeglumine in the rat , 1997, Acta radiologica.

[11]  J. Caillé,et al.  Brain distribution of MRI contrast media in rats after intracisternal injection. , 1987, Journal of neuroradiology. Journal de neuroradiologie.